French drugmaker Sanofi and its US partner Translate Bio will kick off human Phase 1/2 clinical trials for MRT5500, its messenger RNA-based vaccine …
Sanofi’s CEO, Paul Hudson, said that the mRNA-based (messenger Ribonucleic acid) COVID-19 vaccine developed by the pharma giant and Translate Bio will not …
Sanofi (SNY) and Translate Bio (TBIO) have announced that they are expanding their existing 2018 collaboration and license agreement to develop mRNA vaccines …
French drugmaker Sanofi (SNY) said that the U.S.
Shares in Translate Bio (TBIO) surged 24% on Friday, after Sanofi (SNYNF) made several positive comments about the outlook for their joint coronavirus …
Heron Therapeutics Inc (NASDAQ:HRTX) shares soared over 38% to $17.10 in pre-market trading after the company announced positive, top-line results from its recently completed Phase …
